GPCR Podcast, Ben, a postdoctoral fellow at the University of Michigan, walks us through how positive Redefining Opioid Pharmacology Ben and his colleagues discovered that PAMs can dramatically increase That’s huge.” – Ben Clements By combining chronic pain models with receptor-level pharmacology, Ben Ben’s approach injects new life into an area most clinicians have given up on. The GPCR Angle Ben sees GPCRs as untapped goldmines for drug discovery.

Ben Myers!

Ben Clements has been there. This simple advice, passed on to Ben in grad school, has helped him stay sane, focused, and impactful But as Ben points out, burnout is real, and it doesn’t make you better. Imposter Syndrome and Finding Your Place Ben shares the moment he realized he mattered, when he was : Try the Crazy Idea When a collaborator offered a neuroma model (one where opioids usually fail), Ben

Ben Clements has. And that moment, silly as it was, says a lot about how he sees science. Lab Culture Isn’t Just About Productivity Ben and his colleagues work hard in the lab. And we need that to do our best work.” – Ben Clements Mentorship Is the Engine of Science Ben chose When undergraduate students enter the lab, Ben doesn’t just teach them how to pipette, he teaches why

Ben Clements, a tour of our official Dr. Ben Clements   In Episode 166, Ben Clements dives into opioid pharmacology, GPCR-targeted PAMs, and how

Ben Myers!

Ben Myers and Dr. Niña Caculitan.

tagging and interrogation of GPCR co-internalization Kilian Roßmann , Ramona Birke , Joshua Levitz , Ben

3D was used to predict subtype-selective ligands for dopamine receptors and adenosine receptors (He, Ben